Regulacje i polityka gospodarcza · 02/10/2017

National Institute of Drug Abuse Considers Modifying Exclusive Patent License with EncepHeal Therapeutics

The National Institute of Drug Abuse, part of the National Institutes of Health, Department of Health and Human Services, is reviewing a potential modification to its exclusive patent license with EncepHeal Therapeutics, a biotech company based in Winston-Salem, North Carolina, to utilize patented analogues of monamine transporters.